Clinical trial
A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
NCT01382212 is registered in ClinicalTrials.gov with AbbVie (prior sponsor, Abbott) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
- Lead sponsor
- AbbVie (prior sponsor, Abbott)
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2011
- Completion date
- April 30, 2015
- Enrollment
- 13 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
end-stage renal disease, secondary hyperparathyroidism